Literature DB >> 17640292

Fimbriae of uropathogenic Proteus mirabilis.

Sérgio P D Rocha1, Jacinta S Pelayo, Waldir P Elias.   

Abstract

Proteus mirabilis is a common causative agent of cystitis and pyelonephritis in patients with urinary catheters or structural abnormalities of the urinary tract. Several types of fimbriae, which are potentially involved in adhesion to the uroepithelium, can be expressed simultaneously by P. mirabilis: mannose-resistant/Proteus-like (MR/P) fimbriae, P. mirabilis fimbriae (PMF), uroepithelial cell adhesin (UCA), renamed by some authors nonagglutinating fimbriae (NAF), and ambient-temperature fimbriae (ATF). Proteus mirabilis is a common cause of biofilm formation on catheter material and MR/P fimbriae are involved in this process. The considerable serious pathology caused by P. mirabilis in the urinary tract warrants the development of a prophylactic vaccine, and several studies have pointed to MR/P fimbriae as a potential target for immunization. This article reviews P. mirabilis fimbriae with regard to their participation in uropathogenesis, biofilm formation and as vaccine targets.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17640292     DOI: 10.1111/j.1574-695X.2007.00284.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  17 in total

Review 1.  Host-pathogen interactions in urinary tract infection.

Authors:  Greta R Nielubowicz; Harry L T Mobley
Journal:  Nat Rev Urol       Date:  2010-07-20       Impact factor: 14.432

Review 2.  Proteus spp. as Putative Gastrointestinal Pathogens.

Authors:  Amy L Hamilton; Michael A Kamm; Siew C Ng; Mark Morrison
Journal:  Clin Microbiol Rev       Date:  2018-06-13       Impact factor: 26.132

3.  Cystoman® and calculi: a good alternative to standard therapies in preventing stone recurrence.

Authors:  S Proietti; A Giannantoni; L G Luciani; G Sortino; P Graziotti; G Giusti
Journal:  Urolithiasis       Date:  2014-06-28       Impact factor: 3.436

Review 4.  Pathogenesis of Proteus mirabilis Infection.

Authors:  Chelsie E Armbruster; Harry L T Mobley; Melanie M Pearson
Journal:  EcoSal Plus       Date:  2018-02

5.  Degradation of MSCRAMM target macromolecules in VLU slough by Lucilia sericata chymotrypsin 1 (ISP) persists in the presence of tissue gelatinase activity.

Authors:  David I Pritchard; Alan P Brown
Journal:  Int Wound J       Date:  2013-07-09       Impact factor: 3.315

6.  Adhesion, invasion, and agglutination mediated by two trimeric autotransporters in the human uropathogen Proteus mirabilis.

Authors:  Praveen Alamuri; Martin Löwer; Jan A Hiss; Stephanie D Himpsl; Gisbert Schneider; Harry L T Mobley
Journal:  Infect Immun       Date:  2010-08-30       Impact factor: 3.441

7.  Isolation and Characterization of Lytic Proteus Virus 309.

Authors:  Joshua Aaron; Leonardo J van Zyl; Leon M T Dicks
Journal:  Viruses       Date:  2022-06-15       Impact factor: 5.818

8.  A CpxR-Regulated zapD Gene Involved in Biofilm Formation of Uropathogenic Proteus mirabilis.

Authors:  Hong-Han Chen; Chien-Che Chang; Yu-Han Yuan; Shwu-Jen Liaw
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

Review 9.  Merging mythology and morphology: the multifaceted lifestyle of Proteus mirabilis.

Authors:  Chelsie E Armbruster; Harry L T Mobley
Journal:  Nat Rev Microbiol       Date:  2012-10-08       Impact factor: 60.633

10.  Whole-genome sequencing and identification of Morganella morganii KT pathogenicity-related genes.

Authors:  Yu-Tin Chen; Hwei-Ling Peng; Wei-Chung Shia; Fang-Rong Hsu; Chuian-Fu Ken; Yu-Ming Tsao; Chang-Hua Chen; Chun-Eng Liu; Ming-Feng Hsieh; Huang-Chi Chen; Chuan-Yi Tang; Tien-Hsiung Ku
Journal:  BMC Genomics       Date:  2012-12-13       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.